Gentile, M, Shanafelt, TD, Mauro, FR, Reda, G, Rossi, D, Laurenti, L, Del Principe, MI, Cutrona, G, Angeletti, I, Coscia, M
, Herishanu, Y, Chiarenza, A, Molica, S, Ciolli, S, Goldschmidt, N, Angrilli, F, Giordano, A, Rago, A
, Bairey, O, Tripepi, G, Chaffee, KG, Sameer, PA, Vigna, E, Zirlik, K, Shvidel, L, Innocenti, I, Recchia, AG, Di Raimondo, F, Del Poeta, G, Cortelezzi, A, Neri, A, Ferrarini, M, Gaidano, G, Kay, NE, Polliack, A, Foà, R & Morabito, F 2018, '
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment',
European Journal of Haematology, vol. 101, no. 5, pp. 703-706.
https://doi.org/10.1111/ejh.13149